Press Releases
FDA approves linagliptin tablets for the treatment of type 2 diabetes
Boehringer Ingelheim and Eli Lilly and Company announced that the U.S. Food and Drug Administration (FDA) has approved linagliptin tablets, a prescription medication used...
Industry Reports
GlaxoSmithKline Pharmaceuticals Net Sales up 11.4%
GlaxoSmithKline Pharmaceuticals Limited has announced its financial results for the first quarter ended 31st March 2011. Profit after tax but before Exceptional Item grew...
Industry Reports
GlaxoSmithKline Pharmaceuticals profit grows by 16%
GlaxoSmithKline Pharmaceuticals Limited has announced its financial results for the first quarter ended 31st March 2011. Profit after tax but before Exceptional Item grew...
News
Mylan Launches Generic Version of Percodan Tablets
Mylan Inc. announced that its subsidiary Mylan Pharmaceuticals Inc. has launched Oxycodone and Aspirin Tablets USP, 4.8355 mg/325 mg, based on an agreement with...
Press Releases
The European Commission Approves Pfizer’s Revatio for the Treatment of Pulmonary Arterial Hypertension in Children
Pfizer Inc. announced that Revatio® (sildenafil citrate) has been approved by the European Commission for the treatment of pediatric patients aged 1 to 17...
Techno Trends
Novozymes Biopharma collaborates with the University of Oslo to develop enhanced albumin fusion technology
Novozymes Biopharma, part of Novozymes A/S, the world leader in bioinnovation, today unveiled its enhanced next-generation albumin technology, which was developed in collaboration with...
Research Insight
King’s College London Prostate cancer treatment study shows percentage of men who had a radical prostatectomy survived for 15 years
A study co-led by researchers at King’s College London shows that the percentage of men who had a radical prostatectomy (removal of the prostate...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read















